Asfaw Tsegahun
Department of Medical Laboratory Science, Debre Berhan University, Debre Berhan, Ethiopia.
SAGE Open Med. 2023 Apr 29;11:20503121231169389. doi: 10.1177/20503121231169389. eCollection 2023.
This systematic review and meta-analysis aimed to synthesize the available data on rheumatic heart disease in Ethiopia to provide a true figure on the prevalence and distribution of the disease.
Different articles were selected using search terms by different search engines like PubMed, Scopus, Google Scholars, and ScienceDirect and also by obtaining hard copies of locally published articles. The search for original research articles was conducted from December 1 to December 30, 2022. Finally, the priority reporting items of the systematic review and meta-analysis guidelines were used for the literature search strategy, publication selection, data extraction, and reporting of review results. Data quality was checked by the author for similarity of study design and inclusion and exclusion criteria.
A total of sixteen original research articles were included. Nine included articles were from different cardiac patients and seven of the included articles were from children and asymptomatic population. All research papers were summarized in the table clearly with the key information and findings. The prevalence of rheumatic heart disease in cardiac patients from nine included studies was 49.04 (-30.84, 128.92) whereas the prevalence of rheumatic heart disease in children and asymptomatic participants from seven study included was 2.70 (-1181.99, 1187.39) or 27/1000.
This review and meta-analysis found that the prevalence of rheumatic heart disease in Ethiopia is very high in cardiac patients, children, and the asymptomatic population. Therefore, well-designed and evidence-based national prevention and treatment strategies must be in place to prevent the disease and provide timely treatment for patients.
本系统评价和荟萃分析旨在综合埃塞俄比亚风湿性心脏病的现有数据,以提供该病患病率和分布情况的真实数据。
通过不同的搜索引擎(如PubMed、Scopus、谷歌学术和科学Direct)使用搜索词选择不同的文章,同时获取当地发表文章的纸质版。对原始研究文章的检索于2022年12月1日至12月30日进行。最后,系统评价和荟萃分析指南的优先报告项目被用于文献检索策略、出版物选择、数据提取和评价结果报告。作者检查数据质量,以确保研究设计以及纳入和排除标准的相似性。
共纳入16篇原始研究文章。9篇纳入文章来自不同的心脏病患者,7篇纳入文章来自儿童和无症状人群。所有研究论文的关键信息和研究结果都在表格中清晰总结。9项纳入研究中,心脏病患者的风湿性心脏病患病率为49.04(-30.84,128.92),而7项纳入研究中儿童和无症状参与者的风湿性心脏病患病率为2.70(-1181.99,1187.39),即27/1000。
本评价和荟萃分析发现,埃塞俄比亚心脏病患者、儿童和无症状人群中风湿性心脏病的患病率非常高。因此,必须制定精心设计且基于证据的国家预防和治疗策略,以预防该病并为患者提供及时治疗。